The future of cardiometabolic care is being built now. Come help shape it.
GLP-1s are the fastest-adopted drug class in history, however, the healthcare system wasn't built for them. The clinical breakthrough has happened and the harder challenge is now: turning a prescription into a sustained outcome across a fragmented ecosystem of drug makers, pharmacies, digital health programs, employers, and payers.
This exclusive event brings together senior leaders to go beyond the hype and into the hard questions: who closes the access gap, who owns engagement after the prescription is filled, and what does real ecosystem alignment actually look like?
This event has been postponed. We're bringing the conversation to San Francisco and will confirm the date soon. Submit your information to be first on the invite list when registration opens. Attendance is limited to 30 guests.
